stoxline Quote Chart Rank Option Currency Glossary
  
Eupraxia Pharmaceuticals Inc. Common Stock (EPRX)
2.76  0.14 (5.34%)    07-12 13:30
Open: 2.86
High: 2.86
Volume: 7,781
  
Pre. Close: 2.62
Low: 2.76
Market Cap: 98(M)
Technical analysis
2024-07-12 1:20:26 PM
Short term     
Mid term     
Targets 6-month :  3.5 1-year :  4.09
Resists First :  3 Second :  3.5
Pivot price 2.6
Supports First :  2.63 Second :  2.4
MAs MA(5) :  2.67 MA(20) :  2.61
MA(100) :  0 MA(250) :  0
MACD MACD :  -0.1 Signal :  -0.1
%K %D K(14,3) :  75.8 D(3) :  69.3
RSI RSI(14): 58.1
52-week High :  3.28 Low :  2.4
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ EPRX ] has closed Bollinger Bands are 0% narrower than normal.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 2.78 - 2.8 2.8 - 2.81
Low: 2.59 - 2.6 2.6 - 2.62
Close: 2.59 - 2.62 2.62 - 2.64
Company Description

Headline News

Wed, 03 Jul 2024
Berenberg reaffirms ASR Nederland stock Buy rating, sees pension reform boost By Investing.com - Investing.com India

Wed, 03 Jul 2024
Eupraxia Pharmaceuticals' CEO Dr. James Helliwell to Participate in Webinar Event, "Exploring the Rapid Rise of Osteoarthritis" on July 9, 2024 - PR Newswire

Wed, 22 May 2024
Eupraxia Pharmaceuticals Unveils EoE Treatment Advances - TipRanks

Wed, 22 May 2024
Why Urban Outfitters Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket - Benzinga

Tue, 21 May 2024
Eupraxia Reports Promising EoE Treatment Trial Results - TipRanks

Tue, 21 May 2024
Importance of Patient Capital in Life Sciences - MedCity News

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Biotechnology
Shares Out 36 (M)
Shares Float 30 (M)
Held by Insiders 6.9 (%)
Held by Institutions 11.8 (%)
Shares Short 41 (K)
Shares Short P.Month 16 (K)
Stock Financials
EPS -1.21
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0.55
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) -75.6 %
Return on Equity (ttm) -267.3 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) -0.87
Qtrly Earnings Growth 0 %
Operating Cash Flow -22 (M)
Levered Free Cash Flow -11 (M)
Stock Valuations
PE Ratio -2.35
PEG Ratio 0
Price to Book value 5.1
Price to Sales 0
Price to Cash Flow -4.51
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android